Concepedia

Markus Hector

MH

6

Publications

312

Citations

6

H-Index

1996

Active since

Affiliations

Saarland University(Current)

Markus Hector is an author at Saarland University specializing in pharmacology, pharmacotherapy, and drug discovery.

Top concepts

Publications per year

1996–2002

6

Publications

6

Synthesis and Evaluation of Novel Steroidal Oxime Inhibitors of P450 17 (17α-Hydroxylase/C17−20-Lyase) and 5α-Reductase Types 1 and 2

Rolf W. Hartmann, Markus Hector, Samer Haidar et al. · Journal of Medicinal Chemistry · 2000 · 84 citations · Full text

Imidazole substituted biphenyls: A new class of highly potent and in vivo active inhibitors of P450 17 as potential therapeutics for treatment of prostate cancer

Bertil G. Wachall, Markus Hector, Yan Zhuang et al. · Bioorganic & Medicinal Chemistry · 1999 · 60 citations

, , +8

Inhibition of CYP 17, a New Strategy for the Treatment of Prostate Cancer

Rolf W. Hartmann, Peter B. Ehmer, Samer Haidar et al. · Archiv der Pharmazie · 2002 · 59 citations

, , +16

Synthesis and Evaluation of 17-Aliphatic Heterocycle-Substituted Steroidal Inhibitors of 17α-Hydroxylase/C17−20-Lyase (P450 17)

Rolf W. Hartmann, Markus Hector, Bertil G. Wachall et al. · Journal of Medicinal Chemistry · 2000 · 52 citations · Full text

20-Amino and 20,21-aziridinyl pregnene steroids: Development of potent inhibitors of 17α-hydroxylase/C17,20-lyase (P450 17)

Vincent C.O. Njar, Markus Hector, Rolf W. Hartmann · Bioorganic & Medicinal Chemistry · 1996 · 41 citations

, , +11

Rows per page

1–5 of 6